URMD -- Huge market potential Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : URMD -- Huge market potential

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe Sing who wrote (129)	11/7/1997 3:05:00 PM
From: Jeff Clegg	Read Replies (1) of 369

Sounds like sour grapes to me. Do you possess the ability to analyze the revenue impact of the CaverMap aid? Let's take a quick look: A person has prostate cancer and will undergo surgery. There is a 70% chance they will become impotent due to the surgery. Or the surgeon could use the CaverMap aid and decrease the percentage dramatically. Which would you prefer (how high of voice pitch do you want to have?)? URMD should be able to sell an easy 4,000 units in the U.S. alone (rough estimate of $10,000 each) plus charge for disposable units for each surgery (rough estimate of $650 each (extremely conservative)). With the population aging, the 90,000 (number of surgeries that could actually benefit from the device - a very conservative number) annual U.S. prostrate surgeries should increase. And as people become aware of early detection for prostrate cancer, the percentages of prostrate surgeries that can benefit from the device will increase as well. This company is moving from being speculative to growth. Hmmmm, yes you are right, this company has no hope. Watch the upgrades roll in once the company is able to articulate the potential to the market. Regards, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next